Pharmaceuticals: Generic Stocks05-00-2023 21:00:00 PM
The list of companies include ABEO-Abeona Therapeutics Inc, BBIO-BridgeBio Pharma Inc, COCP-Cocrystal Pharma Inc, CPHI-China Pharma Holdings Inc., JAGX-Jaguar Health Inc, LFVN-Lifevantage Corporation, TARO-Taro Pharmaceutical Industries, TXMD-TherapeuticsMD Inc, ZTS-Zoetis Inc, SMTI-Sanara MedTech Inc
* Latest intraday update before market close @ 20:45:28 PM 12/05/2023
Average return is down -0.2%
Median return is down -0.6%
3 out of 8 stocks are up (limited to those with intraday pricing feeds).
Top Movers
TXMD -3.5%BBIO -1.8%ZTS -1.6%TARO -0.9%RDY -0.3%

Aggregated price index with volume information


  • Pharmaceuticals: Generic stocks down 0.3% on average while median return down 0.4% in a day
  • Pharmaceuticals: Generic stocks up 1.1% on average while median return up 2.8% in a week
  • Pharmaceuticals: Generic stocks up 10.4% on average while median return up 10.2% in a month
  • When average return is significantly different from median return, this implies an asymmetry - composite return is driven by some outliners.

Aggregated price index (close) is based on equal weighted constituencies returns. Average short volume and average total volumes are averaged across all volume data among constituencies.

Related Stocks
PE Ratio
P/B (mrq)
P/S (ttm)
Earning Growth
Short %
Held By Institutions %
Price Pattern
Resist Support
Days Since Channel Change
Channel Slope (daily rate %)
13.36286M2%7%59\-/-\Above resistance111-0.3%
-\Above resistance69-0.1%
* P/E and MarketCap are refreshed daily using IEX Cloud service. P/B, P/S, PEG, growth, short%, HelbyInstitute are refreshed weekly using Yahoo feeds. For latest stock stats please visit Yahoo Finance.
* Price Patter: / is upward trend, \ is downward trend, - is sideway. Click on the ticker to go to stock page to see Bayesian Trend model plot of the time series.
* Channel and change points are derived from Bayesian Trend model, where the channel slope is the growth rate while change points are those the model partition the time series.
Detail Performance Summary
  • 1M winners are : Winners for past month are $SMTI 23.0%, $TXMD 12.7%, $TEVA 11.9%, $ZTS 10.7%
  • 1M losers are : Losers for past month are $LFVN -11.6%
  • 1W winners are : Winners for past week are $BBIO 9.6%, $LFVN 5.7%, $SMTI 4.7%, $RDY 2.8%
  • 1W losers are : Losers for past week are $TXMD -12.6%
Pick two stocks to compare:

Correlation Analysis

Index correlation analysis

Correlation for the past month is 8.6%, for the past 3 months is 10.2%

In the past month for a 5 days rolling window, the highest corrrelation is 27.2%, the lowest correlation is -11.7%, the latest correlation is -0.9%

When a correlation deviated from the normal level and goes lower or even negative, it indicates some of stocks have deviated from the normal direction of the group. The deviation could reverse if long term level of correlation was at a higher level. It creates trading opportunities and deserves study whether the deviation is idiosyncratic or systematic.

Among pairwise correlation, the highest correlation is 47.1% between BBIO and SMTI

The lowest correlation is -31.8% between COCP and LFVN

Stock news

    Next year, investors could see growth in these four sectors, Aaron Dunn, portfolio manager at Morgan Stanley, told Yahoo Finance.

    Consumer Experience Leads to Scientific Investigation on Cellular Health Impact When Products are Taken TogetherSALT LAKE CITY, Nov. 29, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq:LFVN), a leading health and wellness company with products designed to activate optimal health processes, today announced that Company scientists have completed a study on the impact Protandim® Nrf2 Synergizer® and TrueScience® Liquid Collagen have on cellular health. The study results showed that when co

    BOTHELL, Wash., Nov. 29, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”), announces the presentation of favorable data demonstrating activity of its potent broad-spectrum PB2 inhibitor CC-42344 against pandemic and seasonal influenza A strains at the World Vaccine Congress West Coast. Cocrystal has initiated a Phase 2a human challenge trial with oral CC-42344 in the UK in subjects infected with influenza A, and plans to begin a Phase 1 trial with inh

    SALT LAKE CITY, Nov. 27, 2023 (GLOBE NEWSWIRE) -- LifeVantage Corporation (Nasdaq: LFVN) (“LifeVantage” or the “Company”), a leading health and wellness company with products designed to activate optimal health processes, today announced that the Board of Directors has appointed Raymond Greer as Chairman of the Board. He succeeds Garry Mauro, who will continue to serve as a member of the Board of Directors. “We want to thank Garry for his many contributions while serving as Chairman. He provided

    BOTHELL, Wash., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Cocrystal Pharma, Inc. (Nasdaq: COCP) (“Cocrystal” or the “Company”) announces that James Martin, Chief Financial Officer and Co-Chief Executive Officer, will present a Company overview at Noble Capital Markets’ 19th Annual Emerging Growth Equity Conference on Monday, December 4 at 1:30 p.m. Eastern time. The conference is being held December 3-5 at the College of Business Executive Education Building at Florida Atlantic University in Boca Raton,

    LifeVantage Corporation ( NASDAQ:LFVN ) stock is about to trade ex-dividend in 3 days. The ex-dividend date occurs one...

    David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

    Most recent data shows that 66% of U.S. households own a pet. Another interesting point is that “85% of dog owners and 76% of cat owners consider their pets to be a member of the family.” A key conclusion from this statistic is that households are investing equally in food and healthcare for their pets. It’s therefore not surprising that pet care stocks have been value creators. Another important point to note is that the above data is just for one country. If we look at global data, the market

    While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

    In a notable insider transaction, Brian Stephenson, the Secretary, Treasurer & CFO of BridgeBio Pharma Inc (NASDAQ:BBIO), sold 22,685 shares of the company on November 17, 2023.